ADVERTISEMENT
Dr. Reddy's And RDIF Commence Clinical Trials For Sputnik V Vaccine In India
01 Dec 2020, 08:34 PM IST 
Save
Sputnik V is the world's first vaccine against COVID-19 based on human adenoviral vector platform.
Dr. Reddy's Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced Tuesday that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India. This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study. The clinical trials are being conducted by JSS Medica...
